Study of how rare DNA repair disorders affect the body over time
Part of Bones, joints & muscles, Brain & nervous system, Cancer, Genetic & congenital, Hormones & metabolism, Skin clinical trials.
This natural history study follows people with specific DNA repair disorders to better understand symptoms and how they change over time. It may help researchers plan future treatments by mapping what complications to expect and when.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be diagnosed with Cockayne syndrome, xeroderma pigmentosum, or trichothiodystrophy (usually confirmed by genetic testing and/or typical symptoms).
- Be at least 6 months old (no upper age limit).
- Have one or more neurological or developmental issues such as delayed walking or speech, unusual muscle tone, trouble walking or frequent falls, tremors, or a smaller-than-typical head.
- Have a condition in the family you can share—either you have one of these disorders or you are a family member of someone who does.
- You must not have had any whole-body gene therapy or cell-based therapy in the past, and you cannot be currently in a treatment/medication-style (interventional) trial.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at “molecular” (DNA-related) features of germ cell tumors in children and teens. It also follows patients over time, which can help researchers understand tumor patterns and improve future care.
This study looks at how young adults aged 15–25 with rare genetic conditions (like certain bone, skin, hearing, or facial conditions) are doing in school, work, and social life. Researchers want to understand what helps or prevents young people with these conditions from being included in their communities.
This study is looking for people with rare, unexplained conditions that cause early intellectual disability and low muscle tone. Researchers want to study your cells and blood to try to find new genetic causes that standard DNA tests missed.
This study uses a new technique called optical mapping to better understand chromosome changes found in children with neurodevelopmental disorders. It aims to give clearer answers to families about these genetic findings.
This study uses genome (DNA) sequencing to look for the genetic cause of rare disorders, especially when the cause is unknown. It may help some families better understand what is driving the condition, using genetic information from the affected person and often their parents.
This study looks at children who may have genetic (inherited) or metabolic (body chemistry) problems, including newborn screening and episodes of trouble. The goal is to better understand these conditions and identify children who may benefit from further care.
Hear when a new Cockayne Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.